Repositrak Stock Performance
| TRAK Stock | 14.29 0.79 5.24% |
The company holds a Beta of 1.99, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ReposiTrak will likely underperform. At this point, ReposiTrak has a negative expected return of -0.35%. Please make sure to check ReposiTrak's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if ReposiTrak performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ReposiTrak has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in November 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Actual Historical Performance (%)
One Day Return 1.78 | Five Day Return (2.12) | Year To Date Return (33.95) | Ten Year Return 43.87 | All Time Return 132.72 |
Forward Dividend Yield 0.0056 | Payout Ratio | Last Split Factor 1:50 | Forward Dividend Rate 0.08 | Dividend Date 2025-11-14 |
1 | Disposition of 2000 shares by Randall Fields of ReposiTrak at 18.4965 subject to Rule 16b-3 | 07/21/2025 |
2 | Disposition of 3500 shares by Randall Fields of ReposiTrak at 18.2716 subject to Rule 16b-3 | 07/23/2025 |
3 | Disposition of 3500 shares by Randall Fields of ReposiTrak at 17.112 subject to Rule 16b-3 | 07/30/2025 |
4 | Disposition of 3500 shares by Randall Fields of ReposiTrak at 16.836 subject to Rule 16b-3 | 08/12/2025 |
| ReposiTrak dividend paid on 14th of August 2025 | 08/14/2025 |
5 | Disposition of 1500 shares by Randall Fields of ReposiTrak at 15.83 subject to Rule 16b-3 | 08/26/2025 |
6 | 21 Snack and Sauce Suppliers Top ReposiTraks List of Companies Preparing for Food Traceability | 09/09/2025 |
7 | Disposition of 3000 shares by Randall Fields of ReposiTrak at 17.0201 subject to Rule 16b-3 | 09/15/2025 |
8 | Disposition of 2535 shares by Randall Fields of ReposiTrak at 17.2325 subject to Rule 16b-3 | 09/17/2025 |
9 | Disposition of 3000 shares by Randall Fields of ReposiTrak at 17.5775 subject to Rule 16b-3 | 09/22/2025 |
10 | Disposition of 4000 shares by Randall Fields of ReposiTrak at 17.3856 subject to Rule 16b-3 | 09/23/2025 |
11 | Randall Fields Sells 4,000 Shares of ReposiTrak Stock | 09/24/2025 |
12 | ReposiTrak Posts Earnings Results | 09/29/2025 |
13 | Investors Will Want ReposiTraks Growth In ROCE To Persist | 10/01/2025 |
14 | ReposiTrak, Inc. Analysts Are Pretty Bullish On The Stock After Recent Results | 10/03/2025 |
15 | 3 Growth Companies With Insider Ownership Up To 30 | 10/08/2025 |
| Begin Period Cash Flow | 25.2 M | |
| Total Cashflows From Investing Activities | 169.00 |
ReposiTrak | Build AI portfolio with ReposiTrak Stock |
ReposiTrak Relative Risk vs. Return Landscape
If you would invest 1,833 in ReposiTrak on July 15, 2025 and sell it today you would lose (404.00) from holding ReposiTrak or give up 22.04% of portfolio value over 90 days. ReposiTrak is currently does not generate positive expected returns and assumes 2.6684% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than ReposiTrak, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ReposiTrak Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ReposiTrak's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ReposiTrak, and traders can use it to determine the average amount a ReposiTrak's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1322
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TRAK |
Estimated Market Risk
| 2.67 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ReposiTrak is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ReposiTrak by adding ReposiTrak to a well-diversified portfolio.
ReposiTrak Fundamentals Growth
ReposiTrak Stock prices reflect investors' perceptions of the future prospects and financial health of ReposiTrak, and ReposiTrak fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ReposiTrak Stock performance.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0728 | ||||
| Profit Margin | 0.31 % | ||||
| Operating Margin | 0.28 % | ||||
| Current Valuation | 254.61 M | ||||
| Shares Outstanding | 18.28 M | ||||
| Price To Earning | 326.08 X | ||||
| Price To Book | 5.71 X | ||||
| Price To Sales | 11.56 X | ||||
| Revenue | 22.61 M | ||||
| Gross Profit | 18.92 M | ||||
| EBITDA | 7.51 M | ||||
| Net Income | 6.98 M | ||||
| Cash And Equivalents | 332.31 M | ||||
| Cash Per Share | 1.94 X | ||||
| Total Debt | 509.97 K | ||||
| Debt To Equity | 0.83 % | ||||
| Current Ratio | 0.90 X | ||||
| Book Value Per Share | 2.71 X | ||||
| Cash Flow From Operations | 8.42 M | ||||
| Earnings Per Share | 0.35 X | ||||
| Market Capitalization | 261.28 M | ||||
| Total Asset | 55.33 M | ||||
| Retained Earnings | (12.84 M) | ||||
| Working Capital | 28.15 M | ||||
| Current Asset | 542.02 M | ||||
| Current Liabilities | 189.38 M | ||||
About ReposiTrak Performance
By examining ReposiTrak's fundamental ratios, stakeholders can obtain critical insights into ReposiTrak's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that ReposiTrak is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.20 | 0.21 | |
| Return On Capital Employed | 0.13 | 0.13 | |
| Return On Assets | 0.13 | 0.13 | |
| Return On Equity | 0.14 | 0.15 |
Things to note about ReposiTrak performance evaluation
Checking the ongoing alerts about ReposiTrak for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ReposiTrak help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ReposiTrak generated a negative expected return over the last 90 days | |
| ReposiTrak is unlikely to experience financial distress in the next 2 years | |
| ReposiTrak currently holds 509.97 K in liabilities with Debt to Equity (D/E) ratio of 0.83, which is about average as compared to similar companies. ReposiTrak has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ReposiTrak's use of debt, we should always consider it together with its cash and equity. | |
| ReposiTrak has a strong financial position based on the latest SEC filings | |
| About 35.0% of ReposiTrak outstanding shares are owned by corporate insiders | |
| Latest headline from simplywall.st: 3 Growth Companies With Insider Ownership Up To 30 |
- Analyzing ReposiTrak's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ReposiTrak's stock is overvalued or undervalued compared to its peers.
- Examining ReposiTrak's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ReposiTrak's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ReposiTrak's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ReposiTrak's stock. These opinions can provide insight into ReposiTrak's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ReposiTrak. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy ReposiTrak Stock please use our How to buy in ReposiTrak Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReposiTrak. If investors know ReposiTrak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReposiTrak listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.126 | Dividend Share 0.071 | Earnings Share 0.35 | Revenue Per Share | Quarterly Revenue Growth 0.111 |
The market value of ReposiTrak is measured differently than its book value, which is the value of ReposiTrak that is recorded on the company's balance sheet. Investors also form their own opinion of ReposiTrak's value that differs from its market value or its book value, called intrinsic value, which is ReposiTrak's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReposiTrak's market value can be influenced by many factors that don't directly affect ReposiTrak's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReposiTrak's value and its price as these two are different measures arrived at by different means. Investors typically determine if ReposiTrak is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReposiTrak's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.